肝细胞癌的基因免疫治疗
摘要
肝细胞癌(hepatocellular carcinoma,HCC)是导致癌性死亡的第三大原因,每年有100万新病例.目前更多的治疗手段是外科、移植、放疗或化疗及基因等综合治疗,其中基因免疫治疗被认为是最有前途的研究方向之一.现仅就肝细胞癌最近的治疗热点基因免疫治疗作一综述.
出处
《温州医学院学报》
CAS
2005年第4期342-343,346,共3页
Journal of Wenzhou Medical College
参考文献19
-
1Jalanko H Ruoslahti E.Differential expression of alphafetoprotein and gamma-glutamyltranspeptidase in chemical and spontaneous hepatocarcinogenesis[J].Cancer Res, 1979,39(9): 3495-3501.
-
2Tabor E.Tumor suppressor genes,growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma[J].J Med Viro1,1994,42(4):357-365.
-
3Vollmer CM, Eilber FC, Butterfield LH,et al. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma[J]. Cancer Res, 1999,59(13):3064-3067.
-
4Anderson SC, Johnson DE, Harris MP, et al. p53 gene therapy in a rat model of hepatocellular carcinoma: Intra-arterial delivery of a recombinant adenovirus[J]. Clin Cancer Res,1998, 4(7): 1649-1659.
-
5Barajas M, Mazzolini G, Genove G,et al. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus,coding for interleukin 12[J]. Hepatology, 2001,33(1):52-61.
-
6Li Y, Yu Dc, Chen Y et al..A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin[J]. Cancer Res,2001, 61(17): 6428-6436.
-
7Pawlik TM, Nakamura H, Yoon SS et al. Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpes virus[J]. Cancer Res,2000, 60(11):2790-2795.
-
8De Weese TL, Van Der Poel H, Li S et al.. A Phase I trial of cv706, a replication-competent, for the treatment of locally recurrent prostate cancer following radiation therapy[J].Cancer Res,2001, 61(20): 7464-7472.
-
9Putzer BM, Stiewe T, Rodicker F, et al. Large nontransplanted hepatocellular carcinoma in woodchucks: Treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes[J].Natl Cancer Inst, 2001, 93(6): 472-479.
-
10Chen L, Ashe S, Brady WA,et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4[J]. Cell, 1992,71(7): 1093-1102.
-
1何天霖,傅传刚.结直肠癌术后癌胚抗原基因疫苗辅助治疗的研究现状[J].中华胃肠外科杂志,2001,4(4):267-269. 被引量：4
-
2李靖,周建波,梁平.肝癌基因治疗研究最新进展[J].重庆医学,2005,34(11):1721-1724. 被引量：1
-
3赵旭飞,沈岩.胰腺癌的综合治疗进展[J].国际外科学杂志,2006,33(3):185-189. 被引量：9
-
4兰英华,李用国,任红.甲胎蛋白与肝细胞癌[J].国际肿瘤学杂志,2004,31(S1):90-93.
-
5李刚,邓林.白细胞介素在人脑胶质瘤基因免疫治疗中的研究[J].中华神经外科疾病研究杂志,2009,8(5):385-388. 被引量：2
-
6叶敏,费哲为.胃癌的基因免疫治疗[J].实用医学杂志,2008,24(4):502-503. 被引量：1
-
7房良华,姜藻.肝癌的基因免疫治疗若干研究[J].东南大学学报（医学版）,2005,24(5):351-354.
-
8孙永明,王海斌,胥正泉,田康松.白细胞介素-4修饰骨肉瘤SAOS-2细胞在SCID小鼠体内基因免疫治疗的研究[J].中华实验外科杂志,2009(9):1229-1229.
-
9王谨,李升平,郑利民.基因修饰T淋巴细胞在肿瘤免疫治疗中的应用[J].中国肿瘤生物治疗杂志,2008,15(3):292-295. 被引量：2
-
10范宝珍,毛宏胜,苏剑.胃肿瘤基因治疗研究[J].世界核心医学期刊文摘（眼科学分册）,2003(4):735-737.
